SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-017697
Filing Date
2022-09-21
Accepted
2022-09-21 18:06:09
Documents
2
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3347
2 POWER OF ATTORNEY poa.htm EX-24.2 4375
  Complete submission text file 0001567619-22-017697.txt   9421
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Issuer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Payne Fletcher (Reporting) CIK: 0001650476 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32001 | Film No.: 221257514